Breaking News Instant updates and real-time market news.

CLSD

Clearside Biomedical

$1.79 /

+0.155 (+9.48%)

10:11
08/09/22
08/09
10:11
08/09/22
10:11

Clearside Biomedical jumps following financing pact with HealthCare Royalty

Shares of Clearside Biomedical (CLSD) are on the rise on Tuesday after the company announced a non-dilutive financing agreement with HealthCare Royalty, supporting progression of CLS-AX clinical program. Alongside its second quarter results, Clearside Biomedical said it had entered into a Royalty Interest Purchase and Sale Agreement with HealthCare Royalty Partners, which may provide the company up to $65 million in non-dilutive funding to support ongoing clinical development of Clearside's pipeline, and pursuant to which HealthCare Royalty Partners will receive all royalties and milestone payments due to Clearside from XIPERE and certain SCS Microinjector license agreements, subject to a cap of 2.5 times the total purchase price paid by HealthCare Royalty under the agreement. The cap may be increased under certain circumstances. In Tuesday morning trading, shares of Clearside have gained about 9% to $1.78.

  • 09

    Aug

  • 09

    Aug

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
EMA accepts Astellas Pharma's authorization application for Fezolinetant » 19:34
09/29/22
09/29
19:34
09/29/22
19:34
ALPMY

Astellas Pharma

$13.09 /

-0.03 (-0.23%)

Astellas Pharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

08/10/22 Citi
Astellas Pharma downgraded to Neutral from Buy at Citi
04/12/22 Citi
Astellas Pharma resumed with a Buy at Citi
02/23/22 Jefferies
Astellas Pharma downgraded to Hold from Buy at Jefferies
ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

Hot Stocks
MoneyLion issues response to Consumer Financial Protection Bureau » 19:25
09/29/22
09/29
19:25
09/29/22
19:25
ML

MoneyLion

/

+

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ML MoneyLion
/

+

ML MoneyLion
/

+

06/27/22 Loop Capital
MoneyLion initiated with a Buy at Loop Capital
03/11/22 Cantor Fitzgerald
MoneyLion price target lowered to $5 from $8 at Cantor Fitzgerald
11/22/21 Cantor Fitzgerald
MoneyLion initiated with an Overweight at Cantor Fitzgerald
11/22/21 Cantor Fitzgerald
MoneyLion initiated with an Overweight at Cantor Fitzgerald
ML MoneyLion
/

+

Hot Stocks
Tupperware announces settlement of SEC probe for divested entity » 19:03
09/29/22
09/29
19:03
09/29/22
19:03
TUP

Tupperware Brands

$6.66 /

-0.72 (-9.76%)

Tupperware Brands…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

08/04/22 Citi
Tupperware Brands price target raised to $11.50 from $8 at Citi
08/02/22 Citi
Tupperware Brands transferred with Neutral rating at Citi
05/05/22 DA Davidson
DA Davidson cuts Tupperware Brands to Neutral as macro and execution weigh on Q1
05/05/22 DA Davidson
Tupperware Brands downgraded to Neutral from Buy at DA Davidson
TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

Hot Stocks
AVCtechnologies intends to effect a 1-for-15 reverse stock split » 18:56
09/29/22
09/29
18:56
09/29/22
18:56
AVCT

AVCtechnologies

/

+

American Virtual Cloud…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVCT AVCtechnologies
/

+

AVCT AVCtechnologies
/

+

Hot Stocks
Morgan Stanley CEO: Unlikely we will have a hard landing » 18:36
09/29/22
09/29
18:36
09/29/22
18:36
MS

Morgan Stanley

$79.85 /

-1.52 (-1.87%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

09/12/22 Deutsche Bank
Morgan Stanley price target lowered to $92 from $105 at Deutsche Bank
09/06/22 Odeon Capital
Morgan Stanley downgraded to Sell from Hold at Odeon Capital
07/15/22 Oppenheimer
Morgan Stanley price target lowered to $93 from $97 at Oppenheimer
07/15/22 BMO Capital
Morgan Stanley price target lowered to $99 from $105 at BMO Capital
MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

Earnings
Micron sees Q2 revenue range similar to Q1 » 18:35
09/29/22
09/29
18:35
09/29/22
18:35
MU

Micron

$50.04 /

-0.95 (-1.86%)

Sees bits up sequentially…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

11:36 Today Lynx
Micron price target raised to $56 from $50 at Lynx
09/27/22 JPMorgan
JPMorgan cuts Micron target but says accumulate on pullbacks
09/27/22 UBS
Micron price target lowered to $75 from $80 at UBS
09/27/22 JPMorgan
Micron price target lowered to $65 from $80 at JPMorgan
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

Hot Stocks
Amylyx announces FDA approval of RELYVRIO for treatment of ALS » 18:31
09/29/22
09/29
18:31
09/29/22
18:31
AMLX

Amylyx

$30.14 /

+0.96 (+3.29%)

Amylyx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

  • 07
    Jan
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

On The Fly
Fly Intel: After-Hours Movers » 18:18
09/29/22
09/29
18:18
09/29/22
18:18
CMTL

Comtech

$9.86 /

-0.42 (-4.09%)

, AMLX

Amylyx

$30.14 /

+0.96 (+3.29%)

, NKE

Nike

$95.40 /

-3.3 (-3.34%)

, UAA

Under Armour

$7.37 /

-0.545 (-6.89%)

, FL

Foot Locker

$32.70 /

-2.24 (-6.41%)

, SKX

Skechers

$34.09 /

-0.305 (-0.89%)

, MU

Micron

$50.04 /

-0.95 (-1.86%)

, RCII

Rent-A-Center

$22.32 /

-1.21 (-5.14%)

Check out this evening's…

ShowHide Related Items >><<
CMTL Comtech
$9.86 /

-0.42 (-4.09%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

MU Micron
$50.04 /

-0.95 (-1.86%)

RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

CMTL Comtech
$9.86 /

-0.42 (-4.09%)

06/15/22 Jefferies
Comtech downgraded to Hold from Buy at Jefferies
06/13/22 Noble Capital
Comtech upgraded to Outperform from Market Perform at Noble Capital
06/10/22 Citi
Comtech price target lowered to $14 from $20 at Citi
10/05/21 Noble Capital
Comtech downgraded to Market Perform from Outperform at Noble Capital
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
UAA Under Armour
$7.37 /

-0.545 (-6.89%)

09/27/22 Baird
Baird removes negative 'Fresh Pick' on Under Armour amid less-defensive shift
09/27/22 Baird
Baird adds positive 'Fresh Pick' on Planet Fitness amid less-defensive shift
08/04/22 Williams Trading
Under Armour downgraded to Sell from Hold at Williams Trading
08/04/22 Barclays
Under Armour price target lowered to $12 from $14 at Barclays
FL Foot Locker
$32.70 /

-2.24 (-6.41%)

08/23/22 Credit Suisse
Foot Locker price target raised to $40 from $31 at Credit Suisse
08/23/22 Deutsche Bank
Foot Locker price target raised to $34 from $31 at Deutsche Bank
08/23/22 UBS
Foot Locker price target raised to $39 from $29 at UBS
08/22/22 B. Riley
Foot Locker price target raised to $36 from $33 at B. Riley
SKX Skechers
$34.09 /

-0.305 (-0.89%)

07/27/22 Wedbush
Skechers price target lowered to $42 from $48 at Wedbush
07/25/22 Deutsche Bank
Skechers price target lowered to $51 from $64 at Deutsche Bank
07/20/22 Stifel
Skechers price target lowered to $45 from $61 at Stifel
07/15/22 UBS
Skechers price target lowered to $56 from $67 at UBS
MU Micron
$50.04 /

-0.95 (-1.86%)

11:36 Today Lynx
Micron price target raised to $56 from $50 at Lynx
09/27/22 JPMorgan
JPMorgan cuts Micron target but says accumulate on pullbacks
09/27/22 UBS
Micron price target lowered to $75 from $80 at UBS
09/27/22 JPMorgan
Micron price target lowered to $65 from $80 at JPMorgan
RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

06/29/22 Stephens
Rent-A-Center downgraded to Equal Weight from Overweight at Stephens
02/25/22 KeyBanc
Rent-A-Center price target lowered to $44 from $68 at KeyBanc
02/25/22 Raymond James
Rent-A-Center downgraded to Outperform from Strong Buy at Raymond James
11/05/21 Raymond James
Rent-A-Center price target lowered to $65 from $70 at Raymond James
CMTL Comtech
$9.86 /

-0.42 (-4.09%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

MU Micron
$50.04 /

-0.95 (-1.86%)

RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

  • 07
    Jan
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

MU Micron
$50.04 /

-0.95 (-1.86%)

CMTL Comtech
$9.86 /

-0.42 (-4.09%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

MU Micron
$50.04 /

-0.95 (-1.86%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

MU Micron
$50.04 /

-0.95 (-1.86%)

Hot Stocks
Rent-A-Center sinks 18% after cutting Q3 guidance, naming new CFO  18:04
09/29/22
09/29
18:04
09/29/22
18:04
RCII

Rent-A-Center

$22.32 /

-1.21 (-5.14%)

 
ShowHide Related Items >><<
RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

06/29/22 Stephens
Rent-A-Center downgraded to Equal Weight from Overweight at Stephens
02/25/22 KeyBanc
Rent-A-Center price target lowered to $44 from $68 at KeyBanc
02/25/22 Raymond James
Rent-A-Center downgraded to Outperform from Strong Buy at Raymond James
11/05/21 Raymond James
Rent-A-Center price target lowered to $65 from $70 at Raymond James
RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

Hot Stocks
Ready Capital announces increase to share buyback program by $25M » 18:02
09/29/22
09/29
18:02
09/29/22
18:02
RC

Ready Capital

$9.76 /

-0.785 (-7.44%)

Ready Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RC Ready Capital
$9.76 /

-0.785 (-7.44%)

RC Ready Capital
$9.76 /

-0.785 (-7.44%)

09/08/22 B. Riley
Ready Capital price target lowered to $16 from $18 at B. Riley
06/28/22 Piper Sandler
Ready Capital price target lowered to $14 from $16 at Piper Sandler
03/11/22 BTIG
Ready Capital coverage transferred at BTIG
12/03/21 B. Riley
Ready Capital price target raised to $18 from $17 at B. Riley
RC Ready Capital
$9.76 /

-0.785 (-7.44%)

  • 12
    Jan
Periodicals
Boeing pauses South Carolina 787 plant operations amid storm, Bloomberg says  18:00
09/29/22
09/29
18:00
09/29/22
18:00
BA

Boeing

$125.35 /

-8.035 (-6.02%)

 
ShowHide Related Items >><<
BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

Hot Stocks
United Natural Foods increasing investment in Shoppers banner » 17:52
09/29/22
09/29
17:52
09/29/22
17:52
UNFI

United Natural Foods

$33.56 /

-2.475 (-6.87%)

United Natural Foods is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

09/28/22 MKM Partners
United Natural Foods price target lowered to $63 from $69 at MKM Partners
09/28/22 Deutsche Bank
United Natural Foods price target lowered to $46 from $54 at Deutsche Bank
09/28/22 Wells Fargo
United Natural Foods price target lowered to $40 from $45 at Wells Fargo
09/28/22 BMO Capital
United Natural Foods price target lowered to $40 from $45 at BMO Capital
UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

Periodicals
China certifies C919 plane in challenge to Airbus, Boeing, Reuters says » 17:44
09/29/22
09/29
17:44
09/29/22
17:44
BA

Boeing

$125.35 /

-8.035 (-6.02%)

, EADSY

Airbus

$21.58 /

-0.272 (-1.24%)

China hosted a ceremony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
EADSY Airbus
$21.58 /

-0.272 (-1.24%)

09/26/22 JPMorgan
Airbus price target lowered to EUR 155 from EUR 175 at JPMorgan
09/06/22 Goldman Sachs
Airbus downgraded to Buy from Conviction Buy at Goldman Sachs
08/03/22 Citi
Airbus price target raised to EUR 171 at Citi
EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

Hot Stocks
Nike sees Q2 revenue up low double digits, gross margins to decline 350-400bps » 17:43
09/29/22
09/29
17:43
09/29/22
17:43
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Says: "For the…

Says: "For the second quarter specifically, we expect reported revenue to grow low double digits on strong consumer demand despite 900 basis points of foreign exchange headwinds. We expect second quarter gross margins to decline approximately 350 to 400 basis points versus the prior year, the largest impact across the fiscal year as we discount out-of-season product more aggressively in a largely promotional marketplace. This will require higher markdowns in our own channels and through wholesale partners. The second quarter also compares to last year's record level of full price realization and includes headwinds from freight, logistics and other supply chain costs as well as foreign exchange." Comments taken from Q1 earnings conference call.

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Nike CFO says FY23 gross margins to decline 200-250bps in FY23 » 17:40
09/29/22
09/29
17:40
09/29/22
17:40
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Sees negative FX headwind…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Nike CFO says China business performance, inventory management ahead of plan » 17:37
09/29/22
09/29
17:37
09/29/22
17:37
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Says: "Brand…

Says: "Brand strength is our competitive advantage, with NIKE setting the pace as Chinese consumers' #1 cool and #1 favorite brand, further extending our lead among teams."

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Miniso's Chairman of the Board to purchase up to $5M in shares » 17:33
09/29/22
09/29
17:33
09/29/22
17:33
MNSO

Miniso

$4.99 /

+0.13 (+2.67%)

Miniso's Chairman of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNSO Miniso
$4.99 /

+0.13 (+2.67%)

MNSO Miniso
$4.99 /

+0.13 (+2.67%)

07/13/22 Goldman Sachs
Miniso price target lowered to $11.90 from $12.20 at Goldman Sachs
06/13/22 Jefferies
Miniso initiated with a Buy at Jefferies
MNSO Miniso
$4.99 /

+0.13 (+2.67%)

MNSO Miniso
$4.99 /

+0.13 (+2.67%)

Hot Stocks
Nike CFO says broader marketplace to be promotional at least through year-end  17:32
09/29/22
09/29
17:32
09/29/22
17:32
NKE

Nike

$95.40 /

-3.3 (-3.34%)

 
ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Nike extends decline, down over 9% afterhours » 17:28
09/29/22
09/29
17:28
09/29/22
17:28
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Shares of Nike are now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Nike CFO Matthew Friend says taking 'decisive action' to reduce inventory » 17:27
09/29/22
09/29
17:27
09/29/22
17:27
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Says promotional activity…

Says promotional activity across the marketplace is accelerating. Says current operating environment continues to be disruptive. Comments taken from Q1 earnings conference call.

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Conference/Events
Immatics management to meet with Jefferies » 17:25
09/29/22
09/29
17:25
09/29/22
17:25
IMTX

Immatics

$9.75 /

+0.27 (+2.85%)

Biotech Analyst Shi to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMTX Immatics
$9.75 /

+0.27 (+2.85%)

IMTX Immatics
$9.75 /

+0.27 (+2.85%)

08/09/22 Chardan
Immatics price target lowered to $28 from $30 at Chardan
12/14/21 SVB Securities
SVB Leerink positive on Bristol-Myers deal, ups Immatics price target to $32
12/14/21 SVB Securities
Immatics price target raised to $32 from $28 at SVB Leerink
IMTX Immatics
$9.75 /

+0.27 (+2.85%)

Hot Stocks
Nike CEO says these are times when strong brands get stronger » 17:22
09/29/22
09/29
17:22
09/29/22
17:22
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Says confident in ability…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Amylyx jumps 9.5% to $33.07 after FDA granted approval of Relyvrio to treat ALS  17:18
09/29/22
09/29
17:18
09/29/22
17:18
AMLX

Amylyx

$30.14 /

+0.96 (+3.29%)

 
ShowHide Related Items >><<
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

  • 07
    Jan
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

Hot Stocks
FDA grants approval of Relyvrio to treat ALS patients to Amylyx » 17:15
09/29/22
09/29
17:15
09/29/22
17:15
AMLX

Amylyx

$30.14 /

+0.96 (+3.29%)

The FDA approved Relyvrio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

  • 07
    Jan
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

Conference/Events
NLS Pharmaceutics to hold a virtual key opinion leader event » 17:13
09/29/22
09/29
17:13
09/29/22
17:13
NLSP

NLS Pharmaceutics

/

+

Virtual Key Opinion…

Virtual Key Opinion Leader Event will review top-line results from the Company's Phase 2a clinical trial evaluating Quilience (Mazindol ER) in the treatment of excessive daytime sleepiness (EDS) and cataplexy, the two core symptoms of narcolepsy on September 30 at 10 am. Webcast Link

ShowHide Related Items >><<
NLSP NLS Pharmaceutics
/

+

NLSP NLS Pharmaceutics
/

+

09/06/22 Laidlaw
NLS Pharmaceutics initiated with a Buy at Laidlaw
07/05/22 Alliance Global Partners
NLS Pharmaceutics initiated with a Buy at Alliance Global Partners

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.